Is GEN undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GEN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GEN (CZK730) is trading above our estimate of fair value (CZK640.43)
Significantly Below Fair Value: GEN is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GEN?
Key metric: As GEN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for GEN. This is calculated by dividing GEN's market cap by their current
earnings.
What is GEN's PE Ratio?
PE Ratio
30.2x
Earnings
US$624.00m
Market Cap
US$18.87b
GEN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: GEN is expensive based on its Price-To-Earnings Ratio (30.2x) compared to the European Software industry average (28.1x).
Price to Earnings Ratio vs Fair Ratio
What is GEN's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
GEN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
30.2x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GEN's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst GEN forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
Kč730.00
Kč723.36
-0.9%
15.2%
Kč871.73
Kč494.77
n/a
9
Nov ’25
Kč680.00
Kč681.84
+0.3%
17.2%
Kč861.29
Kč488.84
n/a
9
Oct ’25
Kč610.00
Kč601.12
-1.5%
12.9%
Kč726.28
Kč476.62
n/a
7
Sep ’25
Kč593.00
Kč601.12
+1.4%
12.9%
Kč726.28
Kč476.62
n/a
7
Aug ’25
Kč606.00
Kč589.39
-2.7%
9.3%
Kč661.43
Kč478.97
n/a
7
Jul ’25
Kč573.00
Kč589.39
+2.9%
9.3%
Kč661.43
Kč478.97
n/a
7
Jun ’25
Kč565.00
Kč590.21
+4.5%
9.6%
Kč658.71
Kč477.00
n/a
7
May ’25
Kč490.00
Kč617.24
+26.0%
9.0%
Kč685.66
Kč496.51
n/a
8
Apr ’25
Kč520.00
Kč614.79
+18.2%
9.0%
Kč673.27
Kč487.54
n/a
8
Mar ’25
Kč496.50
Kč616.73
+24.2%
9.6%
Kč685.40
Kč496.32
n/a
9
Feb ’25
Kč547.00
Kč590.71
+8.0%
10.0%
Kč688.15
Kč481.70
n/a
9
Jan ’25
Kč510.00
Kč560.53
+9.9%
9.4%
Kč607.29
Kč472.33
n/a
8
Dec ’24
Kč484.50
Kč552.12
+14.0%
9.8%
Kč603.18
Kč469.14
n/a
7
Nov ’24
Kč395.00
Kč518.90
+31.4%
8.7%
Kč609.14
Kč473.78
Kč680.00
6
Oct ’24
Kč425.00
Kč518.90
+22.1%
8.7%
Kč609.14
Kč473.78
Kč610.00
6
Sep ’24
Kč465.00
Kč498.56
+7.2%
9.6%
Kč595.05
Kč456.87
Kč593.00
6
Aug ’24
Kč418.50
Kč486.36
+16.2%
9.7%
Kč584.80
Kč449.00
Kč606.00
6
Jul ’24
Kč400.00
Kč509.44
+27.4%
9.5%
Kč593.74
Kč461.80
Kč573.00
6
Jun ’24
Kč384.50
Kč509.44
+32.5%
9.5%
Kč593.74
Kč461.80
Kč565.00
6
May ’24
Kč384.50
Kč521.65
+35.7%
3.0%
Kč546.89
Kč504.82
Kč490.00
5
Apr ’24
Kč379.00
Kč565.31
+49.2%
6.7%
Kč635.42
Kč525.87
Kč520.00
5
Mar ’24
Kč455.00
Kč565.31
+24.2%
6.7%
Kč635.42
Kč525.87
Kč496.50
5
Feb ’24
Kč502.00
Kč565.31
+12.6%
6.7%
Kč635.42
Kč525.87
Kč547.00
5
Jan ’24
Kč480.00
Kč625.85
+30.4%
6.8%
Kč704.57
Kč583.09
Kč510.00
5
Dec ’23
Kč546.00
Kč625.85
+14.6%
6.8%
Kč704.57
Kč583.09
Kč484.50
5
Nov ’23
Kč578.00
Kč637.96
+10.4%
5.3%
Kč693.43
Kč594.37
Kč395.00
5
Analyst Forecast: Target price is less than 20% higher than the current share price.